Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth
2011

Non-Compliance with Growth Hormone Treatment in Children

Sample size: 177 publication Evidence: high

Author Information

Author(s): Wayne S. Cutfield, José G. B. Derraik, Alistair J. Gunn, Kyle Reid, Theresa Delany, Elizabeth Robinson, Paul L. Hofman

Primary Institution: Liggins Institute, University of Auckland, Auckland, New Zealand

Hypothesis

What is the compliance rate of children and adolescents with growth hormone treatment in New Zealand?

Conclusion

Non-compliance with growth hormone treatment is common and associated with reduced linear growth in children.

Supporting Evidence

  • 66% of patients were non-compliant with their GH treatment.
  • Patients with good compliance had significantly greater linear growth.
  • Maori ethnicity was associated with a lower rate of compliance.

Takeaway

Many kids in New Zealand don't take their growth hormone medicine as they should, which can make them grow less.

Methodology

A national survey assessed GH compliance in children receiving government-funded GH over a four-month period.

Potential Biases

Caregiver-reported compliance may overestimate adherence due to social desirability bias.

Limitations

The return of used GH vials was not mandatory, which may have led to underestimation of compliance.

Participant Demographics

Patients were 12.1 years old on average, with 48% males; 75% identified as European & other, 15% Maori, 7% Asian, and 4% Pacific Islander.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016223

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication